FIELD: medicine. SUBSTANCE: method involves applying lys-plasminogen produced by proteolytically splitting glu-plasminogen that protects tissues injured in ischemic state. Lys-plasminogen is applied for treating patients both during reperfusion and after it is over. Lys-plasminogen is optionally administered in combination with thrombolytic therapy when plasminogen tissue activator is applied. EFFECT: enhanced effectiveness of treatment; accelerated anastomosis adhesion; stable hemodynamic state. 33 cl, 4 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TREATING A HEART ATTACK AND ISCHEMIC INJURY WITH HALOGEN COMPOUNDS | 2015 |
|
RU2728790C2 |
| PROTECTIVE COMPOSITIONS FOR ISCHEMIA/REPERFUSION AND METHODS FOR USING THEM | 2008 |
|
RU2459624C2 |
| APOPTOSIS INHIBITORS AND USE THEREOF | 2011 |
|
RU2582247C2 |
| METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION AND ISCHEMIC DAMAGE | 2012 |
|
RU2638807C2 |
| METHOD OF CARDIOPROTECTION AND NEUROPROTECTION USING INTRAVENOUS INTRODUCTION OF HALOGENIC OF FLYING ANESTHETIC | 2003 |
|
RU2350323C2 |
| APPLICATION OF KAURAN COMPOUNDS FOR MEDICINES PRODUCTION | 2004 |
|
RU2345761C2 |
| METHOD FOR CEREBRAL PROTECTION IN RECONSTRUCTIVE SURGERY OF CAROTID ARTERIES | 2004 |
|
RU2279878C2 |
| PREVENTION/REDUCTION OF ISCHEMIA-RELATED DAMAGES | 2018 |
|
RU2768889C2 |
| AGENT, USE THEREOF AND A METHOD OF INCREASING RESISTANCE OF A MAMMALIAN ORGANISM TO ISCHEMIC-REPERFUSION INVOLVEMENT OF THE SMALL INTESTINE | 2018 |
|
RU2729788C2 |
| PHARMACEUTICAL PREPARATION | 2009 |
|
RU2542512C2 |
